Related Experiment Video

Updated: Aug 9, 2026

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells
09:20

In situ Subcellular Fractionation of Adherent and Non-adherent Mammalian Cells

Published on: July 23, 2010

[Effect of small interference RNA on E6, E7 mRNA of human papillomavirus type-18 in cervical cancer cells]

Ping Wang1, Zhu-mei Cui, Bing Luo

  • 1Department of Obstetrics and Gynecology, Afflicated Hospital of Medical College, Qingdao University, Qingdao 266003, China.

Zhonghua Fu Chan Ke Za Zhi
|April 28, 2006
PubMed
Abstract

Insights

Small interference RNA (siRNA) effectively reduced human papillomavirus type-18 (HPV18) E6 and E7 mRNA levels in cervical cancer cells. This targeted RNA interference demonstrates specificity in HeLa cells, impacting cell cycle progression.

Area of Science:

  • Molecular biology
  • Virology
  • Cancer research

Context:

  • Cervical cancer is a significant global health concern, often caused by persistent infection with high-risk human papillomavirus (HPV).
  • HPV types 16 and 18 are the most oncogenic, with their oncoproteins E6 and E7 playing crucial roles in cellular transformation and tumorigenesis.
  • Targeting viral gene expression offers a potential therapeutic strategy for HPV-associated cancers.

Purpose:

  • To investigate the efficacy of small interference RNA (siRNA) in downregulating the expression of E6 and E7 messenger RNA (mRNA) from human papillomavirus type-18 (HPV18) in cervical cancer cells.
  • To assess the impact of siRNA-mediated gene silencing on cell activity and cell cycle distribution in HPV18-infected cervical cancer cells.

Summary:

  • Specific siRNA targeting HPV18 E6 and E7 mRNA were synthesized and transfected into HeLa cells (a human cervical cancer cell line).
  • Methyl thiazolyl tetrazolium (MTT) assays confirmed reduced cell activity post-transfection. Semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) demonstrated significant decreases in HPV18 E6 and E7 mRNA levels at 24, 48, and 72 hours.
  • Flow cytometry analysis revealed a notable increase in cells in the G2 phase and a decrease in the S phase following transfection with HPV18 E6 and E7 siRNA, indicating cell cycle arrest.

Impact:

  • The study confirms the presence and specificity of RNA interference (RNAi) in HeLa cells for targeting HPV18.
  • These findings suggest that siRNA-based therapies could be a viable approach for treating cervical cancer by inhibiting the expression of key HPV oncogenes.
  • Further research into optimizing siRNA delivery and efficacy could lead to novel therapeutic strategies for HPV-driven malignancies.

More Related Videos

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma10:26

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma

Published on: March 11, 2014

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus13:41

Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus

Published on: March 8, 2012

Related Concept Videos

Initiation of Translation02:33

Initiation of Translation

Initiating translation is complex because it involves multiple molecules. Initiator tRNA, ribosomal subunits, and eukaryotic initiation factors (eIFs) are all required to assemble on the initiation codon of mRNA. This process consists of several steps that are mediated by different eIFs.
First, the initiator tRNA must be selected from the pool of elongator tRNAs by eukaryotic initiation factor 2 (eIF2). The initiator tRNA (Met-tRNAi) has conserved sequence elements including modified bases at...
RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA ends...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...